VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance

Author:

ElTanbouly Mohamed A.1,Zhao Yanding23ORCID,Nowak Elizabeth1ORCID,Li Jiannan4,Schaafsma Evelien23,Le Mercier Isabelle5,Ceeraz Sabrina6,Lines J. Louise1,Peng Changwei78ORCID,Carriere Catherine9,Huang Xin9,Day Maria9,Koehn Brent10ORCID,Lee Sam W.11ORCID,Silva Morales Milagros7ORCID,Hogquist Kristin A.78ORCID,Jameson Stephen C.78ORCID,Mueller Daniel78ORCID,Rothstein Jay9,Blazar Bruce R.1012ORCID,Cheng Chao313ORCID,Noelle Randolph J.19ORCID

Affiliation:

1. Department of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

2. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

3. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

4. Adimab LLC, Lebanon, NH, USA.

5. KSQ Therapeutics, Cambridge, MA, USA.

6. Immunology Discovery, Janssen Research and Development LLC, Spring House, PA, USA.

7. Division of Rheumatic and Autoimmune Diseases, Center for Immunology, University of Minnesota, Minneapolis, MN, USA.

8. The Center for Immunology, University of Minnesota, Minneapolis, MN, USA.

9. ImmuNext Corporation, Lebanon, NH, USA.

10. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.

11. Yale University School of Medicine, New Haven, CT, USA.

12. Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.

13. Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Abstract

A VISTA on naïve T cell fate T cell quiescence and tolerance restrain the immune system from becoming overactive and attacking healthy tissue. Negative checkpoint regulators normally limit T cell responses to help safeguard against conditions such as autoimmunity. ElTanbouly et al. report that the checkpoint regulator VISTA (V-type immunoglobulin domain-containing suppressor of T cell activation) restricts early stages of T cell activation by shaping the inherent heterogeneity of the naïve CD4 + T cell compartment to one that is more uniformly quiescent and silent (see the Perspective by Brown and Rudensky). Therapeutic targeting of VISTA using an agonistic antibody in mice curbed the development of graft-versus-host disease and promoted the death of naïve T cells abnormally activated by self-antigen. VISTA thus represents a distinctive immunoregulatory molecule that controls naïve T cell function by maintaining quiescence and peripheral tolerance. Science , this issue p. eaay0524 ; see also p. 247

Funder

NIH Office of the Director

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 142 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3